Paricalcitol Market

Global Paricalcitol Market Size, Share & Trends Analysis Report, by type (High Purity, Low Purity), By Application (Injection Product, Capsule Product), Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024296 | Category : Pharmaceuticals | Delivery Format: /

The Global Paricalcitol Market is estimated to grow at a significant CAGR during the forecast period. Paricalcitol is a synthesised (man-made) version of vitamin D. Calcium absorption from the stomach and calcium function in the body both require vitamin D. Paricalcitol is used to treat and prevent hyperparathyroidism in dialysis patients with chronic renal disease. Hyperparathyroidism is a condition in which the parathyroid glands in the neck overproduce parathyroid hormone (PTH).

This hormone regulates the calcium and phosphorus levels in your blood. Paricalcitol aids in the reduction of PTH, which reduces calcium and phosphorus levels. For the treatment of post-transplantation osteoporosis or in patients with chronic kidney diseases as well as vitamin D deficiency, Paricalcitol is used. Factors such as the rising incidence of chronic renal disease and the rising number of patients with secondary hyperparathyroidism might be attributed to the market's expansion. 

The Paricalcitol medication has been approved by the FDA for use in adults with stage 3 or 4 chronic renal disease who are on dialysis or have a creatinine clearance of less than 30 mL/min, as well as people with secondary hyperparathyroidism who are on dialysis (high levels of parathyroid hormone). Paricalcitol can be given intravenously or orally, depending on the patient's condition and preference; it can also be given as a monthly injection under the skin (subcutaneously).

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segments Covered

o By Type

o By Application

  • Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

  • Competitive Landscape: ChemWerth Inc, ALP Pharm Beijing Co., Ltd, Chongqing Huapont Pharmaceutical Co. Ltd, DISHMAN NETHERLANDS B.V., Haoyuan Chemexpress Co.Ltd.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Paricalcitol Market by Segments,

By Type:

  • High Purity
  • Low Purity

By Application:

  • Injection Product
  • Capsule Product

Global Paricalcitol Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa